Exasol (EXL) H2 2024 earnings summary

Executive summary

• Achieved positive EBITDA of EUR 2.0 million and net income of EUR 0.2 million for 2024, marking the first full-year profit since IPO.

• Revenue grew by 12.9% year-over-year to EUR 39.6 million, driven by upselling and new contracts in focus industries.

• Cash and cash equivalents increased to EUR 15.0 million, exceeding expectations.

• Strategic focus sharpened on finance, healthcare, telecom, utilities, and public sector, with robust ARR growth in these segments.

• Company expects continued growth and improved profitability in 2025.

Financial highlights

• Annual Recurring Revenue (ARR) rose 3.7% to EUR 42.3 million, with 19% ARR growth in focus industries.

• Recurring revenue accounted for 98.8% of total revenue.

• EBITDA improved from EUR -5.7 million in 2023 to EUR 2.0 million in 2024.

• Net income swung from EUR -8.2 million in 2023 to EUR 0.2 million in 2024.

• Operating cash flow turned positive at EUR 1.4 million, up from EUR -6.3 million in 2023.

Outlook and guidance

• For 2025, expects ARR and revenue growth in the mid-single-digit percentage range.

• EBITDA projected to rise by at least 50% to EUR 3–4 million, with continued positive net income.

• Double-digit ARR growth anticipated in focus industries, offset by churn in non-focus sectors.